The effect of amantadine on the recovery of patients with traumatic brain injury
Phase 3
- Conditions
- brain injury.Diffuse traumatic brain injuryS06.2
- Registration Number
- IRCT20190618043934N18
- Lead Sponsor
- Birjand University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 51
Inclusion Criteria
Age more than 16 years
GCS=8
Possibility of receiving medicine through NG or OG tube
Obtaining consent from the patient to enter the study after she regains consciousness and recovers(????)
Exclusion Criteria
Pregnancy
Diabetes disease
Dyslipidemia
Cancer
Congenital, ischemic and atherosclerotic heart disease
Kidney failure
Patients with unknown identity
Kidney disease
Use of dopanergic agents by the patient
Contraindications for the use of amantadine
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Glasgow Coma Scale. Timepoint: First and before the intervention, the third day of the intervention and the seventh day of the intervention. Method of measurement: Using the Glasgow coma criteria table and clinical examination by a neurosurgery assistant.
- Secondary Outcome Measures
Name Time Method